Refine
Has Fulltext
- yes (177)
Is part of the Bibliography
- yes (177)
Year of publication
- 1991 (177) (remove)
Document Type
- Journal article (131)
- Book article / Book chapter (24)
- Conference Proceeding (7)
- Review (6)
- Book (5)
- Report (2)
- Jahresbericht (1)
- Doctoral Thesis (1)
Keywords
- Anorganische Chemie (11)
- Infektionsbiologie (10)
- Organische Chemie (8)
- Toxikologie (8)
- Psychologie (7)
- Biochemie (6)
- Virologie (6)
- Neurobiologie (5)
- Escherichia coli (4)
- Kind (4)
Institute
- Theodor-Boveri-Institut für Biowissenschaften (34)
- Institut für Molekulare Infektionsbiologie (19)
- Institut für Psychologie (bis Sept. 2007) (17)
- Institut für Anorganische Chemie (16)
- Institut für Pharmakologie und Toxikologie (13)
- Institut für Organische Chemie (9)
- Institut für Virologie und Immunbiologie (8)
- Institut für Psychologie (7)
- Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie (Chirurgische Klinik I) (7)
- Neurochirurgische Klinik und Poliklinik (6)
59. Schale (Typus B)
(1991)
56. Schale (Typus B)
(1991)
No abstract available.
Studies were performed in the rabbit aortic rings, precontracted with norepinephrine, to determine the subtype(s) of muscarinic receptors involved in endothelium-dependent relaxation and contraction in the absence of endothelium elicited by cholinergic stimuli. Acetylcholine (ACh) and arecaidine propargyl ester (APE), a M2 and M3 agonist, produced a dose-dependent relaxation and contraction in endothelium-intact and endothelium-denuded rabbit aortic rings, respectively. Both of these responses were blocked by the muscarinic receptor antagonist atropine. M1 selective agonist McN-A-343 [4-[N-(3-chlorophenyl)carbamoyloxy]-2-butinyltrimethylammonium+ ++ chloride] did not produce any effect on the tone of precontracted aortic rings. ACh- and APE-induced relaxation in aortic rings with intact endothelium was selectively blocked by M3 receptor antagonists hexahydrosila-difenidol and p-fluoro-hexahydro-sila-difenidol (pA2 of 7.84 and 7.18) but not by M1 antagonist pirenzepine or M2 receptor antagonists AF-DX 116 [11-(2-[(diethylamino)methyl]- 1-piperidinyl]acetyl)-5, 11-dihydro-6H-pyrido-[2,3-b][1,4]-benzo-diazepin-6-one] and methoctramine. ACh- and APE-induced contraction was inhibited by M2 receptor antagonists AF-DX 116 and methoctramine (pA2 of 7.11 and 6.71) but not by pirenzepine, hexahydro-sila-difenidol or p-fluoro-hexahydro-sila-difenidol. ACh- and APE-induced relaxation or contraction were not altered by nicotinic receptor antagonist hexamethonium or cyclooxygenase inhibitor indomethacin. These data suggest that relaxation elicited by cholinergic stimulin in endothelium-intact aortic rings is mediated via release of endothelium-derived relaxing factor consequent to activation of M3 receptors located on endothelial cells, whereas the contraction in aortic rings denuded of their endothelium is mediated via stimulation of M2 receptors located on smooth muscle cells.
No abstract available.
kulbābu
(1991)
Hethiter und Hurriter
(1991)
No Abstract available
No abstract available.
The melanoma inducing locus of Xiphophorus encodes a tumorigenic version of a novel putative receptor tyrosine kinase (Xmrk). To elucidate the mechanism of oncogenic activation of Xmrk, we compared the structure and expression of two oncogenic loci with the corresponding proto-oncogene. Only minor structural alterations were found to be specific for the oncogenic Xmrk genes. Marked overexpression of the oncogene transcripts in melanoma, which are approximately 1 kb shorter than the proto-oncogene transcript, correlates with the malignancy of the tumors. The tumor transcripts are derived from an alternative transcription start site that is used only in the oncogenic loci. Thus, oncogenic activation of the melanoma inducing Xmrk gene appears primarily to be due to novel transcriptional control and overexpression.
No abstract available.